Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Lundbeck acquires exclusive commercial rights to Sycrest outside U.S., China and Japan

Oct. 13, 2010

Novartis to use ImmunoGen's TAP technology to develop anticancer therapeutics

Oct. 13, 2010

Exelixis and Bristol-Myers Squibb collaborate on multiple small-molecule programs

Oct. 13, 2010

Amylin Pharma to use Affibody's Albumod platform under new license agreement

Oct. 11, 2010

Roche buys rights to hepatitis C therapy danoprevir from InterMune

Oct. 8, 2010

NCI and Lixte Biotechnology collaborate on anticancer agent LB-100

Oct. 8, 2010

Starpharma and Lilly collaborate on dendrimer-drug conjugate development

Oct. 7, 2010

BioRelix and Merck & Co. subsidiary partner to identify antibacterial drug candidates

Oct. 7, 2010

Evotec and Shionogi form multiple-target drug discovery alliance

Oct. 6, 2010

DSP and SanBio develop new stem cell therapy for stroke

Oct. 6, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.